THE PHARMACOKINETIC OF THE MAIN ORAL ANTIBIOTICS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondakova Y., Kondratyeva E., Zyryanov S., Bondareva I., Sherman V., Melyanovskaya Y.EUROPEAN RESPIRATORY JOURNAL. Том 54. 2019.
ФАРМАКОНАДЗОР MonographKolbin A.S., Kolbin A.S., Zyryanov S.K., Zyryanov S.K., Belousov D.Yu., Belousov D.Yu., Логиновская О.А., Матвеев А.В., Romanov B.K., Глаголев С.В., Plavinsky S.L., Burbello A.T., Zagorodnikova K.A., Karpenko L.I.ОКИ: Буки-Веди. 2019. 248 с.
ВОЗРАСТНЫЕ ОСОБЕННОСТИ ФАРМАКОКИНЕТИКИ ЦИПРОФЛОКСАЦИНА У ДЕТЕЙ, БОЛЬНЫХ МУКОВИСЦИДОЗОМ ArticleКондратьева Е.И., Кондакова Ю.А., Зырянов С.К., Бондарева И.Б., Воронкова А.Ю., Шерман В.Д., Мельяновская Ю.Л.Клиническая микробиология и антимикробная химиотерапия. Том 21. 2019. 37 с.
THE USE OF NEW DOSAGE FORMS OF ANTIBIOTICS AS A WAY TO IMPROVE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY ArticleZyryanov S.K., Baibulatova E.A.Antibiotiki i Khimioterapiya. Том 64. 2019. С. 81-91
MODERN APPROACHES TO THE RATIONAL CHOICE OF ANTIBIOTIC FOR TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS ArticleZyryanov S.K., Butranova O.I.Качественная клиническая практика. 2019. С. 89-105
ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ ArticleЗырянов С.К., Белевский А.С., Дьяков И.Н.Астма и аллергия. 2019. С. 28-37
EFFICIENCY AND SAFETY OF OPIOID THERAPY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH CANCER OF THE REFRACTORY IRON: CLINICO-PATHOGENETIC FEATURES ArticleBobrova O.P., Schneider N.A., Petrova M.M., Dmitrenko D.V., Zyryanov S.K., Zobova S.N.Экспериментальная и клиническая гастроэнтерология. 2019. С. 45-51
SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE ArticleShmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 142 с.
AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondratieva E.I., Kondakova Y.A., Zyryanov S.K., Bondareva I.B., Voronkova A.Y., Sherman V.D., Melyanovskaya Y.L., Odinayeva N.D., Dronov I.A.Pediatriya - Zhurnal im G.N. Speranskogo. Том 98. 2019. С. 179-188
THE FIRST RUSSIAN CONSENSUS ON QUANTITATIVE ASSESSMENT OF TREATMENT OUTCOME ArticleArutyunov A.G., Bojcov S.A., Viktorova I.A., Vlasov V.V., Voevoda M.I., Vorob'yov P.A., Drapkina O.M., Zadionchenko V.S., Zarubina T.V., Zyryanov S.K., Karpov R.S., Kobalava Z.D., Kolbasnikov S.V., Lazebnik L.B., Livzan M.A., Malyavin A.G., Martynov A.I., Medvedeva I.V., Moiseev S.V., Napalkov D.A. ...Medical News of North Caucasus. Том 14. 2019. С. 283-301
CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH ArticleTolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 11. 2019. С. 48-60
BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS ArticleDiakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.Medical Technologies. Assessment and Choice. 2019. С. 71-80
GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE ArticleTkacheva O.N., Belenkov Y.N., Karpov Y.A., Zyryanov S.K.Kardiologiia. Том 59. 2019. С. 54-63
QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS ArticleIvanov D.A., Kubaeva M.B., Zyryanov S.K.Фармакоэкономика: теория и практика. Том 7. 2019. С. 38-39
PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION ArticleZyryanov S.K., Diyakov I.N., Avdeev S.N.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 268-278